Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs
Exclusive vacancies may not be shown here, please contact Laura on +44 1494 818 026 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Laura Marsh
Account Manager
+44 1494 818 026

Thank you for all your support over the last few months and a BIG thank you for securing me a position with my new company for the next 9 months.
Julie, 2013

Bristol-Myers Squibb and DTMI form new research alliance

6 March 2012 00:00 in Pharmaceutical Company Product News

Bristol-Myers Squibb has strengthened its links with Duke Translational Medicine Institute (DTMI), a leading university dedicated to healthcare research.

A newly-formed strategic relationship between the two organisations will lead to increased exchange of knowledge between DTMI's researchers and Bristol-Myers Squibb's scientists and project teams, building on decades of collaborations.

Having worked together in the fields of cardiology, endocrinology and oncology in the past, the bodies are now looking to expand into new areas, with the first joint project focusing on the development of a new idiopathic pulmonary fibrosis drug.

Elliott Sigal, executive vice-president, chief scientific officer and president of research and development at Bristol-Myers Squibb, said: "Our hope is that this partnership will allow the organisations to collaborate on projects involving all phases of research, development and disease education."

Last month, the company announced the provision of a series of grants to hepatitis projects in China and India, as part of its commitment to supporting global health initiatives.ADNFCR-8000103-ID-801310379-ADNFCR

Other news stories from 06/03/2012

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd